Science Corporation
136 posts

Science Corporation
@ScienceCorp_
Building a brighter tomorrow enabled by neural engineering
Katılım Temmuz 2025
1 Takip Edilen2.8K Takipçiler

Science CEO @maxhodak_ joined @ashleevance for @corememory's first live event for a conversation on neural engineering, the science of restoring vision, and where the field is headed.
youtube.com/watch?v=Ve61_0…

YouTube
English

Geographic atrophy due to AMD is a leading cause of blindness, affecting more than 5 million people worldwide – a condition experts once considered irreparable.
Popular Mechanics looks at the breakthroughs redefining what's possible for patients, including our PRIMA retinal implant, shown in clinical trials published in @NEJM to restore meaningful central vision.
popularmechanics.com/science/health…
English


Science CEO @maxhodak_ joined @semafor Tech Editor @ReedAlbergotti on stage at First Principles for a wide-ranging conversation on longevity, Science's PRIMA retinal prosthesis and Vessel organ perfusion programs, and the philosophy of identity and BCI.

English
Science Corporation retweetledi

Science Co-founder and CEO, @maxhodak_, is speaking at Startup School 2026!
He and his team are developing retinal implants and neural interfaces for patients with vision loss and neurological disease, advancing the frontier of human + computer interaction.
ycombinator.com/startupschool
English

Science CEO @maxhodak_ spoke at TECH by @handelsblatt about the PRIMA implant for blindness caused by AMD/GA – and the landmark clinical trial published in The @NEJM.
Germany has been a key partner in this work from the beginning. Several PRIMA clinical trial centers were based there, and we expect it to be the first market where PRIMA is commercially available later this year.
English
Science Corporation retweetledi

Our portfolio founder Max Hodak, Duke BME alumnus and Neuralink co-founder, is building the future of vision restoration at Science Corporation with clinical success. They are pushing the frontier of neuroscience, AI, and human health. Congrats @maxhodak_ and @ScienceCorp_ team!

English
Science Corporation retweetledi

Full podcast episode with @rauchg, @maxhodak_, and @bscholl.
40 minutes of unreleased material.
The AI Industrial Revolution
Part 1: Waste Tokens, Save Time
0:00 Three Frontier Founders
1:27 AI Software Factories
4:15 Waste Tokens, Save Time
5:47 Models Instructing Humans
9:29 Is Pure Software Dead?
12:03 You Don't Get Stuck Anymore
Part 2: Vibe Coding Hardware
14:39 Vibe Coding a Turbine Blade
18:07 Open Source Compounds China's Advantage
20:15 You Always Want the Smartest Model
22:44 Software Still Needs Hands
24:43 Humans Are Becoming Verifiers
Part 3: The Regulatory Frontier
27:53 The Regulatory Red Queen Race
32:32 Why There's No Innovation in Healthcare
36:49 We Need a True 50-State Experiment
40:31 China's FDA Is Beating Ours
43:37 Healthcare Is a Communist Society Inside Capitalism
45:57 Sid's Story: N-of-1 Medicine
Part 4: The Autonomous Company
47:49 Autonomous Infrastructure
51:25 Your Job Is to Train the Agent
54:54 The Next Lord of the Rings
59:08 What's Your Definition of Art?
1:05:00 Can AI Have New Ideas?
1:07:03 A Large Number of Small Teams
English

Congratulations to Daniel Palanker, PRIMA original inventor and professor of ophthalmology at Stanford University, on receiving the 2027 Friedenwald Award from the @ARVOinfo, one of the highest honors in ophthalmic research.
Palanker's foundational work on photovoltaic retinal implants is what made PRIMA possible.
English

Science CEO, Max Hodak will join @handelsblatt's @FelixHoltermann at TECH by Handelsblatt, Europe's premier conference for technology, innovation, and future business models, on Monday to discuss the future of brain-computer interfaces.
Max recently spoke with Handelsblatt about our PRIMA retinal implant, the first treatment to restore vision in clinical trials for certain patients with advanced geographic atrophy associated with age-related macular degeneration.
handelsblatt.com/technik/forsch…
English

“Max Hodak is working on the future … The first practical test for this goal is a product called ‘PRIMA’—a microchip smaller than a grain of rice that is implanted not in the brain, but under the retina.”
Science CEO, @maxhodak_, spoke with @handelsblatt about our PRIMA retinal implant, the first treatment to restore vision in clinical trials for certain patients with advanced geographic atrophy associated with age-related macular degeneration.
handelsblatt.com/technik/forsch…
English
